A new look at dry eye disease and its treatment

J. Daniel Nelson; Harold Helms; Richard Fiscella; Yvonne Southwell; Jan D. Hirsch

doi:10.1007/BF02854841

A new look at dry eye disease and its treatment

J. Daniel Nelson, Harold Helms, Richard Fiscella, Yvonne Southwell, Jan D. Hirsch

Research output: Contribution to journal › Review article › peer-review

85 Scopus citations

Abstract

This review examines the impact of moderate to severe dry eye disease on daily life and medical-resource utilization. The results suggest that current treatment paradigms can lead to unacceptable costs in both quality of life and progressive use of healthcare resources. Evidence linking this disease to T-cell-mediated inflammatory processes lays the foundation for understanding the clinical benefits of topical cyclosporine, an immunomodulatory and anti- inflammatory agent.

Original language	English (US)
Pages (from-to)	84-93
Number of pages	10
Journal	Advances in Therapy
Volume	17
Issue number	2
DOIs	https://doi.org/10.1007/BF02854841
State	Published - 2000
Externally published	Yes

Keywords

Cyclosporine
Dry eye
Inflammatory response

Access

10.1007/BF02854841

OpenUrl availability

Full text

Cite this

@article{ad16f6da09e04356a46a64314dc5bbd8,

title = "A new look at dry eye disease and its treatment",

abstract = "This review examines the impact of moderate to severe dry eye disease on daily life and medical-resource utilization. The results suggest that current treatment paradigms can lead to unacceptable costs in both quality of life and progressive use of healthcare resources. Evidence linking this disease to T-cell-mediated inflammatory processes lays the foundation for understanding the clinical benefits of topical cyclosporine, an immunomodulatory and anti- inflammatory agent.",

keywords = "Cyclosporine, Dry eye, Inflammatory response",

author = "Nelson, {J. Daniel} and Harold Helms and Richard Fiscella and Yvonne Southwell and Hirsch, {Jan D.}",

year = "2000",

doi = "10.1007/BF02854841",

language = "English (US)",

volume = "17",

pages = "84--93",

journal = "Advances in Therapy",

issn = "0741-238X",

publisher = "Health Communications Inc.",

number = "2",

}

TY - JOUR

T1 - A new look at dry eye disease and its treatment

AU - Nelson, J. Daniel

AU - Helms, Harold

AU - Fiscella, Richard

AU - Southwell, Yvonne

AU - Hirsch, Jan D.

PY - 2000

Y1 - 2000

N2 - This review examines the impact of moderate to severe dry eye disease on daily life and medical-resource utilization. The results suggest that current treatment paradigms can lead to unacceptable costs in both quality of life and progressive use of healthcare resources. Evidence linking this disease to T-cell-mediated inflammatory processes lays the foundation for understanding the clinical benefits of topical cyclosporine, an immunomodulatory and anti- inflammatory agent.

AB - This review examines the impact of moderate to severe dry eye disease on daily life and medical-resource utilization. The results suggest that current treatment paradigms can lead to unacceptable costs in both quality of life and progressive use of healthcare resources. Evidence linking this disease to T-cell-mediated inflammatory processes lays the foundation for understanding the clinical benefits of topical cyclosporine, an immunomodulatory and anti- inflammatory agent.

KW - Cyclosporine

KW - Dry eye

KW - Inflammatory response

UR - http://www.scopus.com/inward/record.url?scp=0033916501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033916501&partnerID=8YFLogxK

U2 - 10.1007/BF02854841

DO - 10.1007/BF02854841

M3 - Review article

C2 - 11010059

AN - SCOPUS:0033916501

SN - 0741-238X

VL - 17

SP - 84

EP - 93

JO - Advances in Therapy

JF - Advances in Therapy

IS - 2

ER -

A new look at dry eye disease and its treatment

Abstract

Keywords

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this